BioSpace News Archive

New services combine the Company’s iPSC-derived human cells and electrophysiological expertise with Axion Biosystems’ Maestro Pro MEA platform

AlzeCure Pharma AB announced that the company has received a second abstract approved for poster presentation at the annual Alzheimer’s conference CTAD, Clinical Trials in Alzheimer’s Disease, which this year will be held completely digitally on November 4-7.

University of North Carolina researchers are seeking more than 6,000 participants aged 18 years and over, with first-hand experience of eating disorders to enroll in the world’s largest ever genetic research study into three complex, devastating mental illnesses.

Itamar Medical Ltd., a leading medical device and digital health company focused on the diagnosis of sleep apnea and other respiratory sleep disorders, reported preliminary unaudited revenue results for the third quarter 2020 and announced revenue guidance for the full year 2020.

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange, announced positive findings from a study evaluating MN-001 in an acute liver injury model will be presented at The Liver Meeting Digital Experience™ 2020, an event of the American Association for the Study of Liver Diseases.

The most comprehensive data solution in the industry, comprised of over 215,000 cases of real-world patient records with integrated molecular and clinical outcomes data, offers an unmatched resource for developing a better understanding of the unique molecular mechanisms of cancer

Pluristem Therapeutics Inc., a leading regenerative medicine company developing a platform of novel biological products, announced that it has received clearance from the safety committee of an investigator initiated Phase I/II study to move forward with patient enrollment for cohort II.

MaxCyte, Inc., a global cell-based therapies and life sciences company, announces a senior leadership promotion and appointments for two key vice president roles.

Primary endpoint of asthma worsening not met in LEDA Study, however consistent numeric reductions ranging from 32-35% observed across all three GB001 groups

Spinal cord stimulation systems are used to modulate the nervous system to improve biological functioning of spinal cord.